HCW Biologics
HCWB
HCWB
18 hedge funds and large institutions have $1.4M invested in HCW Biologics in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 6
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$903K | |
| 2 | +$15.2K | |
| 3 | +$7K | |
| 4 |
Renaissance Technologies
New York
|
+$6.69K |
Top Sellers
| 1 | -$25K | |
| 2 | -$22.3K | |
| 3 | -$4.62K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.81K |